# BriaCell Therapeutics Corp.: Form 8-K, filed Feb 5, 2025

- Company: [BriaCell Therapeutics Corp.](/companies/bctx.md) (CIK 1610820)
- Form: 8-K
- Filed: 2025-02-05
- Accepted by EDGAR: Feb 5, 2025, 17:02 ET
- Period: 2025-02-03
- Accession: 0001493152-25-005043
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1610820/000149315225005043/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1610820/000149315225005043/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1610820/000149315225005043/form8-k.htm

Filed Feb 5, 2025.
Source: SEC EDGAR, the filing index for accession 0001493152-25-005043. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.